Effect of dietary phosphorus restriction on serum fibroblast growth factor 23 (FGF23) levels in patients with chronic kidney disease
Not Applicable
- Conditions
- Chronic kidney disease
- Registration Number
- JPRN-UMIN000003049
- Lead Sponsor
- Kobe University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1, Patients with appetite loss 2, Patients taking vitamin D 3, Patients with rapidly deteriorated renal function 4, Patients who do not agree with participation in this study 5, Patients who are inappropriate for study inclusion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference of change in serum FGF23 levels before and after dietary phosphorus restriction between CKD stage 1,2 and stage 4,5
- Secondary Outcome Measures
Name Time Method Effect of serum phosphate, parathyroid hormone, 1,25D, daily phosphate excretion, and daily protein intake on change of serum FGF23 levels